Thiazolidinediones double fracture risk in women with type 2 diabetes

22 January 2009 Print this article Comments Share this article
Clinicians are advised to reconsider the use of thiazolidinediones in women with type 2 diabetes following research showing that long-term use doubles the risk of fracture in this population....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites